Journal of Neurology and Neurorehabilitation Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Perspective - Journal of Neurology and Neurorehabilitation Research (2024) Volume 9, Issue 6

Neurological Disorders in Children: Diagnosis, Management, and Future Perspectives

Peter Fullerton *

Division of Medical Genetics, University of Utah, USAria

*Corresponding Author:
Peter Fullerton
Division of Medical Genetics, University of Utah, USA
E-mail: fpeter@uu.us.co

Received: 21-Oct-2024, Manuscript No. JNNR-24-155310; Editor assigned: 22-Oct-2024, PreQC No. JNNR-24-155310(PQ); Reviewed: 05-Nov-2024, QC No. JNNR-24-155310; Revised: 11-Nov-2024, Manuscript No. JNNR-24-155310(R); Published: 18-Nov-2024, DOI: 10.35841/aajnnr-9.6.231

Citation: : Fullerton P. Neurological disorders in children: Diagnosis, management, and future perspectives. J Neurol Neurorehab Res.2024;9(6):231

Introduction

Neurological disorders in children encompass a wide range of conditions affecting the developing brain, spinal cord, and peripheral nervous system [1]. These disorders, such as epilepsy, cerebral palsy, autism spectrum disorders, and neuromuscular conditions, often manifest through developmental delays, motor impairments, seizures, or behavioral challenges [2]. Early and accurate diagnosis is critical for optimizing outcomes, as many neurological conditions benefit from timely intervention [3].

The diagnostic process involves a combination of clinical assessments, neuroimaging, genetic testing, and electrophysiological studies. Pediatric neurologists work closely with other specialists to identify underlying causes and tailor treatment plans [4]. For instance, advanced imaging techniques like MRI and CT scans can reveal structural abnormalities, while genetic testing helps uncover hereditary or chromosomal disorders [5].

Management strategies for these disorders are multifaceted, involving medication, physical and occupational therapy, behavioral interventions, and in some cases, surgical procedures [6]. Antiepileptic drugs, for example, are often the first line of treatment for seizure disorders, while spasticity in cerebral palsy may be addressed with botulinum toxin injections or orthopedic surgery [7]. Holistic approaches incorporating educational support and counseling for families are essential to address the broader psychosocial impacts of these conditions [8].

Emerging research continues to shed light on innovative therapies and interventions. Advances in neurogenetics and regenerative medicine offer promising avenues for treating previously untreatable conditions [9]. Neuroplasticity, the brain’s ability to reorganize itself, is a focal point in developing therapies that leverage the inherent adaptability of the pediatric brain [10].

Conclusion

The integration of artificial intelligence and machine learning in diagnostic and treatment modalities is expected to revolutionize pediatric neurology. Early detection tools powered by AI can predict developmental disorders, enabling proactive interventions. Collaborative efforts among clinicians, researchers, and policymakers are essential to address the growing burden of neurological disorders in children and ensure equitable access to cutting-edge care.

References

  1. Gordon-Lipkin E, Banwell B. An update on multiple sclerosis in children: diagnosis, therapies, and prospects for the future. Expert Rev Clin Immunol. 2017;13(10):975-89.

    2. Indexed at, Google Scholar, Cross Ref

  2. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056-66.

    3. Indexed at, Google Scholar, Cross Ref

  3. Peluso S, De Rosa A, De Lucia N, et al. Animal-assisted therapy in elderly patients: evidence and controversies in dementia and psychiatric disorders and future perspectives in other neurological diseases. J Geriatr Psychiatry Neurol. 2018;31(3):149-57.

    4. Indexed at, Google Scholar, Cross Ref

  4. Boelens JJ, Orchard PJ, Wynn RF. Transplantation in inborn errors of metabolism: current considerations and future perspectives. Br J Haematol. 2014;167(3):293-303.

    5. Indexed at, Google Scholar, Cross Ref

  5. Yang ZL, Zhang LJ. PET/MRI of central nervous system: current status and future perspective. European radiology. 2016;26:3534-41.

    6. Indexed at, Google Scholar, Cross Ref

  6. Manti S, Tosca MA, Licari A, et al. Cough remedies for children and adolescents: current and future perspectives. Paediatr Drugs. 2020;22:617-34.

    7. Indexed at, Google Scholar, Cross Ref

  7. Di Bonaventura C, Labate A, Maschio M, et al. AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives. Expert Opin Pharmacother. 2017;18(16):1751-64.

    8. Indexed at, Google Scholar, Cross Ref

  8. Kumar AV, Kumar S, Garg VK, et al. Future perspectives for automated neurodegenerative disorders diagnosis: Challenges and possible research directions. Neurodegenerative Disorder. 2023;255-267.

    9. Google Scholar

  9. Persico AM, Arango C, Buitelaar JK, et al. Unmet needs in paediatric psychopharmacology: present scenario and future perspectives. Eur Neuropsychopharmacol. 2015;25(10):1513-31.

    10. Indexed at, Google Scholar, Cross Ref

  10. Walter U, Dressler D. Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives. Expert Rev Neurother. 2014;14(8):923-36.

    11. Indexed at, Google Scholar, Cross Ref

Get the App